In this review article, we will provide an overview of the current understanding of the integral role of IL-6 in the development and progression of PC and discuss the potential therapeutic implications in cancers that commonly cause PC, including ovarian cancer, gastric cancer, colorectal cancer and ovarian cancer. This evidence concerns the gene IL6 and gastric cancer.